Correlation Between Ibio and Allogene Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ibio and Allogene Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ibio and Allogene Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ibio Inc and Allogene Therapeutics, you can compare the effects of market volatilities on Ibio and Allogene Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ibio with a short position of Allogene Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ibio and Allogene Therapeutics.

Diversification Opportunities for Ibio and Allogene Therapeutics

0.04
  Correlation Coefficient

Significant diversification

The 3 months correlation between Ibio and Allogene is 0.04. Overlapping area represents the amount of risk that can be diversified away by holding Ibio Inc and Allogene Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Allogene Therapeutics and Ibio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ibio Inc are associated (or correlated) with Allogene Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Allogene Therapeutics has no effect on the direction of Ibio i.e., Ibio and Allogene Therapeutics go up and down completely randomly.

Pair Corralation between Ibio and Allogene Therapeutics

Given the investment horizon of 90 days Ibio Inc is expected to generate 3.05 times more return on investment than Allogene Therapeutics. However, Ibio is 3.05 times more volatile than Allogene Therapeutics. It trades about 0.07 of its potential returns per unit of risk. Allogene Therapeutics is currently generating about -0.06 per unit of risk. If you would invest  122.00  in Ibio Inc on September 1, 2024 and sell it today you would earn a total of  172.00  from holding Ibio Inc or generate 140.98% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Ibio Inc  vs.  Allogene Therapeutics

 Performance 
       Timeline  
Ibio Inc 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Ibio Inc are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of very weak forward indicators, Ibio displayed solid returns over the last few months and may actually be approaching a breakup point.
Allogene Therapeutics 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Allogene Therapeutics are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very weak essential indicators, Allogene Therapeutics may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Ibio and Allogene Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Ibio and Allogene Therapeutics

The main advantage of trading using opposite Ibio and Allogene Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ibio position performs unexpectedly, Allogene Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Allogene Therapeutics will offset losses from the drop in Allogene Therapeutics' long position.
The idea behind Ibio Inc and Allogene Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Complementary Tools

Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Fundamental Analysis
View fundamental data based on most recent published financial statements
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios